325 related articles for article (PubMed ID: 22223396)
1. Design and synthesis of 2-iminothiazolidin-4-one moiety-containing compounds as potent antiproliferative agents.
Zhai X; Li W; Chen D; Lai R; Liu J; Gong P
Arch Pharm (Weinheim); 2012 May; 345(5):360-7. PubMed ID: 22223396
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of novel rhodanine-containing sorafenib analogs as potential antitumor agents.
Li W; Zhai X; Zhong Z; Li G; Pu Y; Gong P
Arch Pharm (Weinheim); 2011 Jun; 344(6):349-57. PubMed ID: 21433057
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological activities of sorafenib derivatives as antitumor agents.
Yao J; He Z; Chen J; Sun W; Fang H; Xu W
Bioorg Med Chem Lett; 2012 Nov; 22(21):6549-53. PubMed ID: 23021967
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, antimicrobial and cytotoxic activities of some 5-arylidene-4-thioxo-thiazolidine-2-ones.
Gouveia FL; de Oliveira RM; de Oliveira TB; da Silva IM; do Nascimento SC; de Sena KX; de Albuquerque JF
Eur J Med Chem; 2009 May; 44(5):2038-43. PubMed ID: 19027993
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of indazole based diarylurea derivatives and their antiproliferative activity against tumor cell lines.
Zhao CR; Wang RQ; Li G; Xue XX; Sun CJ; Qu XJ; Li WB
Bioorg Med Chem Lett; 2013 Apr; 23(7):1989-92. PubMed ID: 23454017
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors.
Lv PC; Zhou CF; Chen J; Liu PG; Wang KR; Mao WJ; Li HQ; Yang Y; Xiong J; Zhu HL
Bioorg Med Chem; 2010 Jan; 18(1):314-9. PubMed ID: 19914835
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 1H-pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line.
El-Gamal MI; Sim TB; Hong JH; Cho JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2011 Mar; 344(3):197-204. PubMed ID: 21384419
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiproliferative activity of novel diaryl ureas possessing a 4H-pyrido[1,2-a]pyrimidin-4-one group.
Yao P; Zhai X; Liu D; Qi BH; Tan HL; Jin YC; Gong P
Arch Pharm (Weinheim); 2010 Jan; 343(1):17-23. PubMed ID: 19927308
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and structure-activity relationships of antiproliferative 1,3-disubstituted urea derivatives.
Li HQ; Zhu TT; Yan T; Luo Y; Zhu HL
Eur J Med Chem; 2009 Feb; 44(2):453-9. PubMed ID: 18514972
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives.
Zheng M; Xu C; Ma J; Sun Y; Du F; Liu H; Lin L; Li C; Ding J; Chen K; Jiang H
Bioorg Med Chem; 2007 Feb; 15(4):1815-27. PubMed ID: 17157510
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxicity studies of novel 2-Hydrazonylpyrido[2,3-b]pyrazin-3(4H)-ones.
Zhang G; Liu Y; Wang S; Zhou C; Huang Q; Gong P
Arch Pharm (Weinheim); 2012 Jan; 345(1):49-56. PubMed ID: 21953529
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel 6-hydrazinyl-2,4-bismorpholino pyrimidine and 1,3,5-triazine derivatives as potential antitumor agents.
Zhu W; Liu Y; Zhao Y; Wang H; Tan L; Fan W; Gong P
Arch Pharm (Weinheim); 2012 Oct; 345(10):812-21. PubMed ID: 22707438
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and antitumor activities of novel bis-aryl ureas derivatives as Raf kinase inhibitors.
Zhan W; Li Y; Huang W; Zhao Y; Yao Z; Yu S; Yuan S; Jiang F; Yao S; Li S
Bioorg Med Chem; 2012 Jul; 20(14):4323-9. PubMed ID: 22721924
[TBL] [Abstract][Full Text] [Related]
14. Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents.
Wu J; Yu L; Yang F; Li J; Wang P; Zhou W; Qin L; Li Y; Luo J; Yi Z; Liu M; Chen Y
Eur J Med Chem; 2014 Jun; 80():340-51. PubMed ID: 24794770
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and antiproliferative activity of 3,4-diarylpyrazole-1-carboxamide derivatives against melanoma cell line.
El-Gamal MI; Choi HS; Cho HG; Hong JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2011 Nov; 344(11):745-54. PubMed ID: 21954060
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and structure-activity relationships of novel 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents.
Tang Q; Zhao Y; Du X; Chong L; Gong P; Guo C
Eur J Med Chem; 2013 Nov; 69():77-89. PubMed ID: 24012712
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and cytotoxic activity of novel spin-labeled rotenone derivatives.
Liu YQ; Ohkoshi E; Li LH; Yang L; Lee KH
Bioorg Med Chem Lett; 2012 Jan; 22(2):920-3. PubMed ID: 22204911
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and antitumour activity of bisquinoline derivatives connected by 4-oxy-3-fluoroaniline moiety.
Li S; Huang Q; Liu Y; Zhang X; Liu S; He C; Gong P
Eur J Med Chem; 2013 Jun; 64():62-73. PubMed ID: 23644189
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing pyridazinone moiety as potential antitumor agents.
Zhou S; Liao H; He C; Dou Y; Jiang M; Ren L; Zhao Y; Gong P
Eur J Med Chem; 2014 Aug; 83():581-93. PubMed ID: 24996144
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticancer activity of Indolin-2-one derivatives bearing the 4-thiazolidinone moiety.
Wang S; Zhao Y; Zhu W; Liu Y; Guo K; Gong P
Arch Pharm (Weinheim); 2012 Jan; 345(1):73-80. PubMed ID: 21932254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]